Sanofi-Aventis Czech Republic made a net profit of CZK 15.2 mil with revenues of CZK 7,268 mil in 2017, down by 58.8% and up by 8.47%, respectively, compared to the previous year. This translates into a net margin of 0.210%.
On the operating level, EBITDA reached CZK 50.7 mil, up 152% compared to the previous year. Over the last five years, the company's EBITDA has fallen 8.91% a year on average.
The company generated cash, defined by a sum of net profit and depreciation, of CZK 27.0 mil or 0.371% of sales. When investments are excluded, free cash flow reached CZK -200 mil, or -2.75% of sales in 2017.
In the last five years, the company generated free cash flow of CZK 569 mil. That compares to a cumulative net profit of CZK 177 mil in the same period.
You can see all the company’s data at Sanofi-Aventis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
